Omega Healthcare Investors (OHI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Voting matters and shareholder proposals
Proposal 4 seeks approval to amend the charter to increase the number of authorized shares of common stock; NYSE has determined this is a "routine" matter eligible for discretionary broker voting.
Approval of Proposal 4 requires an affirmative vote by a majority of outstanding shares entitled to vote; abstentions or failures to vote count as votes against.
Brokers may vote at their discretion on Proposal 2 (ratification of EY as independent auditor for 2025) and Proposal 4 if no instructions are provided by beneficial owners.
Shareholder rights and capital structure
An amendment to the charter is proposed to increase the number of authorized shares of common stock, impacting future capital structure.
Audit committee and external auditor matters
Proposal 2 involves the ratification of Ernst & Young (EY) as the independent auditor for fiscal year 2025, with brokers allowed discretionary voting if no instructions are given.
Latest events from Omega Healthcare Investors
- Strong 2025 results and 2026 outlook driven by higher earnings, investments, and portfolio strength.OHI
Q4 20255 Feb 2026 - Consistent high-yield growth, strong financials, and demographic tailwinds drive expansion.OHI
Investor presentation5 Feb 2026 - Q2 net income and FFO rose, AFFO guidance increased, but operator and regulatory risks remain.OHI
Q2 20242 Feb 2026 - Q3 FAD and net income rose, AFFO guidance raised, but operator and regulatory risks persist.OHI
Q3 202417 Jan 2026 - Q4 delivered strong growth, decade-low leverage, and a robust 2025 outlook with U.K. investments.OHI
Q4 20248 Jan 2026 - Q1 2025 net income and AFFO rose sharply, driving higher guidance and robust investments.OHI
Q1 202525 Dec 2025 - Board recommends FOR all proposals, citing strong performance and enhanced ESG focus.OHI
Proxy Filing1 Dec 2025 - Board recommends voting for all proposals, citing strong performance and governance.OHI
Proxy Filing1 Dec 2025 - Q3 2025 delivered higher earnings, raised guidance, and strong investment-driven growth.OHI
Q3 20251 Nov 2025